Federal Project Grant Award Summary

The National Institute on Drug Abuse (NIDA) awarded The Leland Stanford Junior University a $692,570 Project Grant on June 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct epidemiological modeling research addressing the intersection of opioid use disorder (OUD), homelessness, and related communicable diseases. The research will develop novel model-based approaches to assess how housing provision and medication-assisted treatment interventions impact health outcomes for people experiencing homelessness (PEH) with OUD, while examining epidemiological links to HIV, hepatitis C virus (HCV), and other infectious diseases. The project will incorporate economic analyses to evaluate the broad societal costs, benefits, and savings of various intervention strategies and will identify barriers and enablers to successful implementation.

Deliverables from this research will provide clinicians, policymakers, and community organizations with epidemiological evidence and policy guidance on how integrated housing and OUD treatment strategies can efficiently mitigate the health consequences of homelessness and opioid use, reduce incidence of HIV and HCV, and improve quality of life outcomes. The project period extends through March 31, 2031, and will be performed at Stanford University's Palo Alto, California facility. This award supports implementation research aligned with NIDA's priority to expand evidence-based treatment access for underserved populations, including individuals experiencing homelessness.